Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma

References

• Russo AE, Strong VE. Gastric cancer etiology and management in Asia and the west. Annu Rev Med. 2019;70(1):353–367.
   PubMedGoogle Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Sarvizadeh M, Hasanpour O, Ghale-Noie ZN, et al. Allicin and digestive system cancers: from chemical structure to its therapeutic opportunities. Front Oncol. 2021;11: 650256–650256.
   PubMed Web of Science ®Google Scholar
• Pourhanifeh MH, Vosough M, Mahjoubin-Tehran M, et al. Autophagy-related microRNAs: possible regulatory roles and therapeutic potential in and gastrointestinal cancers. Pharmacol Res. 2020;161:105133.
   PubMed Web of Science ®Google Scholar
• Morshedi K, Borran S, Ebrahimi MS, et al. Therapeutic effect of curcumin in gastrointestinal cancers: a comprehensive review. Phytother Res. 2021. DOI:https://doi.org/10.1002/ptr.7119
   Google Scholar
• Ashrafizadeh M, Zarrabi A, Hashemipour M, et al. Sensing the scent of death: modulation of microRNAs by curcumin in gastrointestinal cancers. Pharmacol Res. 2020;160:105199.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Yang D, Yu J, Han B, et al. Long non-coding RNA expression patterns in stomach adenocarcinoma serve as an indicator of tumor mutation burden and are associated with tumor-infiltrating lymphocytes and microsatellite instability. Front Cell Dev Biol. 2021;9:618313.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu X, Gu J, et al. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Mol Genet Genomic Med. 2020;8(11):e1512.
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang Y, Cheng M, et al. Weighted gene coexpression network analysis of features that control cancer stem cells reveals prognostic biomarkers in lung adenocarcinoma. Front Genet. 2020;11:311.
   PubMed Web of Science ®Google Scholar
• Liao Y, Xiao H, Cheng M, et al. Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in lung squamous cell carcinoma. Front Genet. 2020;11:427.
   PubMed Web of Science ®Google Scholar
• Pan H, Guo C, Pan J, et al. Construction of a competitive endogenous RNA network and identification of potential regulatory axis in gastric cancer. Front Oncol. 2019;9:912.
   PubMed Web of Science ®Google Scholar
• Hong W, Liang L, Gu Y, et al. Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma. Mol Ther Nucleic Acids. 2020;22:937–947.
   PubMedGoogle Scholar
• Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123.
   PubMed Web of Science ®Google Scholar
• Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458–472.
   PubMed Web of Science ®Google Scholar
• Martínez-Camblor P, Pardo-Fernández JC. Smooth time-dependent receiver operating characteristic curve estimators. Stat Methods Med Res. 2018;27(3):651–674.
   PubMed Web of Science ®Google Scholar
• Liao Y, Yin G, Fan X. The positive lymph node ratio predicts survival in T(1-4)N(1-3)M(0) non-small cell lung cancer: a nomogram using the SEER database. Front Oncol. 2020;10:1356.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
   PubMed Web of Science ®Google Scholar
• Binatti A, Bresolin S, Bortoluzzi S, et al. iWhale: a computational pipeline based on Docker and SCons for detection and annotation of somatic variants in cancer WES data. Brief Bioinform. 2020;22(3):bbaa065.
   Google Scholar
• Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–1756.
   PubMed Web of Science ®Google Scholar
• Ayers M, Lunceford J, Nebozhyn M, et al. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930–2940.
   PubMed Web of Science ®Google Scholar
• Hugo W, Zaretsky JM, Sun L, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35–44.
   PubMed Web of Science ®Google Scholar
• Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One. 2014;9(9):e107468.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• König IR, Fuchs O, Hansen G, et al. What is precision medicine? Eur Respir J. 2017;50(4):1700391.
   PubMed Web of Science ®Google Scholar
• Xu S, Kong D, Chen Q, et al. Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017;16(1):129.
   PubMed Web of Science ®Google Scholar
• Li B, Cui Y, Diehn M, et al. Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non-small cell lung cancer. JAMA Oncol. 2017;3(11):1529–1537.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Bao S, Yan C, et al. Computational principles and practice for decoding immune contexture in the tumor microenvironment. Brief Bioinform. 2020;22(3):bbaa075.
   Google Scholar
• Sun J, Zhang Z, Bao S, et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020;8(1):e000110.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhang Z, Bao S, et al. Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer. Brief Bioinform. 2020;22(3):bbaa047.
   Google Scholar
• Rahimian N, Razavi ZS, Aslanbeigi F, et al. Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol. 2021;161(3):896–912.
   PubMed Web of Science ®Google Scholar
• Hashemipour M, Boroumand H, Mollazadeh S, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021;161(1):314–327.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Hamblin MR. Regulation of glycolysis by non-coding RNAs in cancer: switching on the warburg effect. Mol Ther Oncolytics. 2020;19:218–239.
   PubMed Web of Science ®Google Scholar
• Mahjoubin-Tehran M, Rezaei S, Jesmani A, et al. New epigenetic players in stroke pathogenesis: from non-coding RNAs to exosomal non-coding RNAs. Biomed Pharmacother. 2021;140: 111753–111753.
   PubMed Web of Science ®Google Scholar
• Hashemian SM, Pourhanifeh MH, Fadaei S, et al. Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis. Mol Ther Nucleic Acids. 2020;21:51–74.
   PubMedGoogle Scholar
• Razavi ZS, Asgarpour K, Mahjoubin-Tehran M, et al. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Mol Ther Oncolytics. 2021;21:220–241.
   PubMed Web of Science ®Google Scholar
• Shafabakhsh R, Arianfar F, Vosough M, et al. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther. 2021. DOI:https://doi.org/10.1038/s41417-020-00272-7
   PubMed Web of Science ®Google Scholar
• Zong Z, Li H, Yu ZM, et al. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer. Gastroenterol Hepatol. 2020;43(10):598–606.
   PubMed Web of Science ®Google Scholar
• Zha Z, Zhang P, Li D, et al. Identification and construction of a long noncoding RNA prognostic risk model for stomach adenocarcinoma patients. Dis Markers. 2021;2021:8895723.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Wang J. Discovery of a novel three-long non-coding RNA signature for predicting the prognosis of patients with gastric cancer. J Gastrointest Oncol. 2020;11(4):760–769.
   PubMed Web of Science ®Google Scholar
• Cai C, Yang L, Tang Y, et al. Prediction of overall survival in gastric cancer using a nine-lncRNA. DNA Cell Biol. 2019;38(9):1005–1012.
   PubMed Web of Science ®Google Scholar
• Cheng P. A prognostic 3-long noncoding RNA signature for patients with gastric cancer. J Cell Biochem. 2018;119(11):9261–9269.
   PubMed Web of Science ®Google Scholar
• Chen JF, Wu P, Xia R, et al. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol Cancer. 2018;17(1):6.
   PubMed Web of Science ®Google Scholar
• Zhang ZX, Liu ZQ, Jiang B, et al. BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1. Biochem Biophys Res Commun. 2015;465(2):225–231.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang L, Zhang Y, et al. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother. 2015;72:109–112.
   PubMed Web of Science ®Google Scholar
• Meng Y, Liu YL, Li K, et al. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: a meta-analysis. Medicine (Baltimore). 2019;98(21):e15793.
   PubMed Web of Science ®Google Scholar
• Wang L, Chunyan Q, Zhou Y, et al. BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients. Eur Rev Med Pharmacol Sci. 2017;21(18):4064–4070.
   PubMed Web of Science ®Google Scholar
• Ding L, Wang L, Li Z, et al. The positive feedback loop of RHPN1-AS1/miR-1299/ETS1 accelerates the deterioration of gastric cancer. Biomed Pharmacother. 2020;124:109848.
   PubMed Web of Science ®Google Scholar
• Zhen-Hua W, Yi-Wei G, Li-Qin Z, et al. Silencing of LncRNA C1RL-AS1 suppresses the malignant phenotype in gastric cancer cells via the AKT/β-catenin/c-myc pathway. Front Oncol. 2020;10:1508.
   PubMed Web of Science ®Google Scholar
• Yu L, Luan W, Feng Z, et al. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p. Dig Liver Dis. 2021;53(2):238–244.
   PubMedGoogle Scholar
• Han H, Wang S, Meng J, et al. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2. Oncogene. 2020;39(42): 6513–6528.
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pagès F, Sautès-Fridman C, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.
   PubMed Web of Science ®Google Scholar
• Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25(18):2586–2593.
   PubMed Web of Science ®Google Scholar
• Wakabayashi O, Yamazaki K, Oizumi S, et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci. 2003;94(11):1003–1009.
   PubMed Web of Science ®Google Scholar
• Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med. 2017;377(25):2500–2501.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang N, Li X, et al. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia. Gastric Cancer. 2021;24(4):823–834.
   PubMed Web of Science ®Google Scholar